Table 3.

Multivariate Coxregression of predictors of survival

Factor	Beta	p-value	HR	95% CI
Age	0.038259	0.024	1.039	1.005	1.074
Gender	− 0.45256	0.232	0.636	0.303	1.335
Race (Caucasian)		0.522
Black	0.833344	0.254	2.301	0.549	9.643
Other	0.124869	0.885	1.133	0.208	6.185
Body Mass Index	− 0.00904	0.729	0.991	0.943	1.042
Tumor size	0.015873	0.763	1.016	0.914	1.13
Vascular invasion	0.192272	0.673	1.212	0.497	2.956
Diagnosis (HCC/CCC)		0.213
Pancreatic, gallbladder, stomach	− 0.23699	0.776	0.789	0.155	4.022
Other primary cancers with liver metastases	0.571544	0.172	1.771	0.779	4.025
Neuroendocrine	− 0.52763	0.352	0.590	0.194	1.792
Treatment (TACE)		0.228
None	− 1.62455	0.027	0.197	0.046	0.834
Systemic chemotherapy	− 0.69315	0.195	0.500	0.175	1.426
90Y	− 1.46968	0.085	0.230	0.043	1.224
Radiofrequency ablation	− 0.87948	0.146	0.415	0.126	1.36
Resection or Whipple	− 0.4943	0.352	0.610	0.216	1.725
Quality of life	0.0001	0.988	1.000	0.968	1.033
Depression	− 0.22941	0.628	0.795	0.315	2.009
Fatigue	0.007968	0.712	1.008	0.967	1.051
Smoking	− 0.4385	0.292	0.645	0.286	1.457
Social support	− 0.81871	0.012	0.441	0.233	0.833
Daytime sleep dysfunction	0.239017	0.362	1.270	0.76	2.123
Sleep duration (linear)	0.133656	0.392	1.143	0.842	1.551
Sleep duration (quadratic)	− 0.001	0.787	0.999	0.991	1.007
Physically activity (inactive)		0.441
Moderately active	− 0.39008	0.423	0.677	0.26	1.758
Very active	0.193097	0.629	1.213	0.554	2.655